Table 1 Characteristics of 58 NM patients
Clinical characteristics | # of patients (%) |
|---|---|
Gender | |
 Male | 27 (46.6) |
 Female | 31 (53.4) |
Age (year) | |
 Median (range) | 55 (23–77) |
Primary cancer | |
 Lung cancer | 42 (72.4) |
 Gastric cancer | 4 (6.9) |
 Breast cancer | 3 (5.2) |
 Rectal cancer | 2 (3.4) |
 Prostatic cancer | 1 (1.7) |
 Parotid carcinoma | 1 (1.7) |
 Lymphoma | 1 (1.7) |
 Glioblastoma | 1 (1.7) |
 Unknown malignancy | 3 (5.2) |
First symptom with NM | 10 (17.2) |
Diagnostic basis | |
 CSF cytology | 44 (75.9) |
 Neuroimaging findings | 8 (13.8) |
 CSF ctDNA | 6 (10.3) |
Treatment regimen (CSF samples) | |
 Intrathecal chemotherapy and systemic therapy | 30 (48.4) |
 Intrathecal chemotherapy without systemic therapy | 11 (17.7) |
 Systemic therapy without intrathecal chemotherapy  No therapy | 12 (19.4) 9 (28.5) |
Hydrocephalus | |
 Yes | 5 (8.6) |
 No | 53 (91.4) |